Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoon, Young Kyung | - |
dc.contributor.author | Lee, Seung Eun | - |
dc.contributor.author | Lee, Juneyoung | - |
dc.contributor.author | Kim, Hyun Jeong | - |
dc.contributor.author | Kim, Jeong Yeon | - |
dc.contributor.author | Park, Dae Won | - |
dc.contributor.author | Sohn, Jang Wook | - |
dc.contributor.author | Kim, Min Ja | - |
dc.date.accessioned | 2021-09-07T09:49:21Z | - |
dc.date.available | 2021-09-07T09:49:21Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2011-08 | - |
dc.identifier.issn | 0305-7453 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/111863 | - |
dc.description.abstract | Objectives: The aim of this study was to identify the risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium (VREF) in intensive care units (ICUs). Methods: A retrospective case-control study was performed in the ICUs of a university hospital in Korea from September 2006 to July 2009. VREF carriage was identified through weekly active surveillance rectal cultures. Clinical characteristics and the risk factors for VREF acquisition were compared between cases with prolonged VREF carriage (>= 5 weeks, n = 58) and controls with shorter VREF carriage (< 3 weeks, n = 36) in a multivariate logistic regression model. The effect of vancomycin consumption on vancomycin-resistant enterococci (VRE) colonization pressure was investigated using time-series analysis with an autoregressive error model. Results: Out of a total of 6327 rectal swab cultures examined, 1915 (30.3%) specimens from 266 patients were positive for VREF. The weekly VRE colonization pressure ranged from 0.77% to 42.42%. Vancomycin use after VREF acquisition significantly increased VREF carriage (adjusted odds ratio = 4.09; 95% confidence interval = 1.32-12.65). The case group had higher in-hospital mortality than the control group [21 (36.2%) versus 4 (11.1%), P = 0.007]. Increment of VRE colonization pressure was significantly associated with vancomycin consumption of 1 week before (i.e. time t-1) (P = 0.0028) and moderately associated with that of the corresponding week (i.e. time t) (P = 0.0595). Conclusions: Vancomycin use in patients with VREF colonization might prolong the duration of carriage. Restriction of vancomycin use should be strengthened in these patients through infection control measures. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | OXFORD UNIV PRESS | - |
dc.subject | STAPHYLOCOCCUS-AUREUS | - |
dc.subject | COLONIZATION | - |
dc.subject | STOOL | - |
dc.subject | BACTEREMIA | - |
dc.subject | AMPICILLIN | - |
dc.subject | MORTALITY | - |
dc.subject | INFECTION | - |
dc.subject | OUTBREAK | - |
dc.subject | DURATION | - |
dc.subject | THERAPY | - |
dc.title | Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoon, Young Kyung | - |
dc.contributor.affiliatedAuthor | Lee, Juneyoung | - |
dc.contributor.affiliatedAuthor | Park, Dae Won | - |
dc.contributor.affiliatedAuthor | Sohn, Jang Wook | - |
dc.contributor.affiliatedAuthor | Kim, Min Ja | - |
dc.identifier.doi | 10.1093/jac/dkr204 | - |
dc.identifier.scopusid | 2-s2.0-79960447644 | - |
dc.identifier.wosid | 000292696400023 | - |
dc.identifier.bibliographicCitation | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, v.66, no.8, pp.1831 - 1838 | - |
dc.relation.isPartOf | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | - |
dc.citation.title | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | - |
dc.citation.volume | 66 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 1831 | - |
dc.citation.endPage | 1838 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Microbiology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | STAPHYLOCOCCUS-AUREUS | - |
dc.subject.keywordPlus | COLONIZATION | - |
dc.subject.keywordPlus | STOOL | - |
dc.subject.keywordPlus | BACTEREMIA | - |
dc.subject.keywordPlus | AMPICILLIN | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | INFECTION | - |
dc.subject.keywordPlus | OUTBREAK | - |
dc.subject.keywordPlus | DURATION | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordAuthor | ICUs | - |
dc.subject.keywordAuthor | infection control | - |
dc.subject.keywordAuthor | time-series analysis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.